About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Los Angeles | 83 Studies

Clinical Trials HypertensionLos Angeles

Hypertension Clinical Trials in Los Angeles

Find 83 clinical trials for hypertension near Los Angeles, California. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 83 trials

Not yet recruitingEnhancing Mental and Physical Health of Women Veterans 3.0Women Veterans are the fastest growing segment of VA users, with most users in midlife.NCT07356479·West Los Angeles, California RecruitingStudy to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years…NCT05587712·Los Angeles, California and 34 others

Hypertension Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedExercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With AmbrisentanThe purpose of this study is to determine the clinical characteristics and hemodynamic profiles that predict exercise induced pulmonary hypertension in 15 patients with systemic…NCT01051960·Los Angeles, California

TerminatedChronic Sildenafil for Severe Diaphragmatic HerniaThe purpose of this study is to test if sildenafil is effective in the treatment of infants with severe congenital diaphragmatic hernia (determined by the presence of prolonged…NCT00133679·Los Angeles, California and 2 others

CompletedValidation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary EmbolismPotential outcomes after PE occur on a spectrum: complete recovery, exercise intolerance from deconditioning/anxiety, dyspnea from concomitant cardiopulmonary conditions, dyspnea…NCT05568927·Fresno, California and 7 others

CompletedEfficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous PatientsThe main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.NCT05397600·Chandler, Arizona and 63 others

CompletedA Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled HypertensionThe purpose of this study is to evaluate the effect of ION904 on plasma angiotensinogen (AGT) in participants with uncontrolled hypertension.NCT05314439·Cypress, California and 7 others

UnknownLong-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAHAn Open-Label Long-Term Safety Study of Inhaled Nitric Oxide (iNO) for Pulmonary Arterial Hypertension (PAH)NCT02652429·Birmingham, Alabama and 16 others

TerminatedAn Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFEThis is a multicenter, open-label trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension (PH) associated with…NCT02633293·Birmingham, Alabama and 91 others

CompletedAn Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial HypertensionThis study provided/continued to provide oral treprostinil (UT-15C SR; treprostinil diethanolamine) to eligible subjects who participated in Studies TDE-PH-202, TDE-PH-203…NCT01027949·Birmingham, Alabama and 133 others

Active not recruitingA Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDThis Phase 3, 2-part, open-label, multicenter study aims to demonstrate the safety and tolerability of L606 in patients with PAH or PH-ILD.NCT04691154·Scottsdale, Arizona and 7 others

TerminatedIloprost Power Disc-15 in Pulmonary Arterial HypertensionA Phase IIIb, Multicenter, Open-Label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When…NCT00723554·Mobile, Alabama and 35 others

TerminatedEfficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)To evaluate the efficacy and safety of 26-weeks of treatment with riociguat vs. placebo in patients with symptomatic PH (pulmonary hypertension) associated with IIP (idiopathic…NCT02138825·Los Angeles, California and 92 others

TerminatedDORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionThis is a double-blind, active-controlled, long-term study of a new experimental drug called darusentan.NCT00389675·Birmingham, Alabama and 98 others

CompletedPhase III Randomized Study of UT-15 in Patients With Primary Pulmonary HypertensionOBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.NCT00004497·Torrance, California and 6 others

CompletedFREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)This study was an international, multicenter, randomized (2:1 active:placebo), double-blind, placebo-controlled study in subjects with PAH who were NOT currently receiving…NCT00325403·Birmingham, Alabama and 76 others

CompletedGB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)The primary objective for this trial is to determine the effect of GB002 (seralutinib) on improving pulmonary hemodynamics in subjects with World Health Organization (WHO) Group 1…NCT04456998·Phoenix, Arizona and 62 others

Active not recruitingDelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support StudyThe purpose of the DelIVery for PAH clinical study is to evaluate the safety of the Medtronic Model 10642 Implantable Intravascular Catheter when used with the Medtronic…NCT01321073·Birmingham, Alabama and 7 others

Active not recruitingEnhancing Mental and Physical Health of Women VeteransWomen Veterans are the fastest growing segment of VA users.NCT05050266·West Los Angeles, California

CompletedCardiovascular Risk Screening and Risk Reduction in Women VetsCardiovascular (CV) disease is the number one cause of death in American women, and all adult women are potentially at risk for CV disease.NCT02991534·Sepulveda, California and 3 others

PreviousPage 4 of 5Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia